English | Español
Patient Daily | Feb 9, 2026

Study finds hundreds of potential food allergy risks but rules out vaccine connection
Patient Daily | Feb 9, 2026

Companies advance new Duchenne muscular dystrophy treatments amid scrutiny over existing gene therapies
Patient Daily | Feb 9, 2026

Penn Medicine researchers use advanced imaging tools to reveal disease mechanisms
Patient Daily | Feb 9, 2026

FARE urges further action after Congress passes PBM reform affecting epinephrine access
Patient Daily | Feb 9, 2026

FDA faces major leadership turnover and regulatory shifts following Trump administration actions
Patient Daily | Feb 8, 2026

AstraZeneca acquires full rights to AbelZeta’s cancer therapy for $630 million
Patient Daily | Feb 8, 2026

GSK acquires RAPT Therapeutics for $2.2B under new CEO Luke Miels
Patient Daily | Feb 8, 2026

Biohaven outlines new strategy after setbacks and prepares muscle-sparing drug study

Trending
+ Pharmaceuticals
Patient Daily | Mar 4, 2026

Gene therapies for sickle cell disease face slow uptake despite early promise
+ Pharmaceuticals
Patient Daily | Mar 7, 2026

FDA prepares decisions on key drugs from BMS, GSK, Aldeyra and others
+ Regulatory
A. B. Abbott | Mar 4, 2026

Rep. Pappas: Proposed federal student loan policy ‘will make it harder for nursing students to access the loans they need’
+ Pharmaceuticals
Patient Daily | Mar 4, 2026

Congress approves record $315 million for ALS research amid new treatment efforts